If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSainsbury's Regulatory News (SBRY)

Share Price Information for Sainsbury's (SBRY)

Share Price is delayed by 15 minutes
Get Live Data
338.50    0.00 (0.00%)
Bid:
0.00
Ask:
350.00
Spread: 12.40 (3.673%)
Market Cap: £7.42b
SBRY Live PriceLast checked at - London Stock Exchange

Intraday Sainsbury's Share Chart

Form 8.3 - [HOME/SBRY]

24 Aug 2016 15:30

RNS Number : 0491I
Syquant Capital
24 August 2016
Β 

Table

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Identity of the person whose positions/dealings are being disclosed:

SYQUANT CAPITAL

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Home Retail Group Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

23th August 2016

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

YES - J Sainsbury Plc

Β 

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

10p ORD

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

(2) Derivatives (other than options):

49,304,508

6.06

(3) Options and agreements to purchase/sell:

TOTAL:

49,304,508

6.06

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other executive options)

Β 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

Β 

Β 

Β 

(b) Derivatives transactions (other than options)

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

ORD

CFD

Increasing a long position

50,000

160.80 GBp

Β 

(c) Options transactions in respect of existing securities

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercising

Β 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

Β 

N/A

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

N/A

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Β 

Β 

Date of disclosure:

24th August 2016

Contact name:

Laurent Boscherel

Telephone number:

+33 1 42 56 56 27

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RETDMGZRZDMGVZM
Date   Source Headline
20th Jul 202110:00 amRNSAdditional Listing
16th Jul 202110:00 amRNSAdditional Listing
13th Jul 202110:00 amRNSAdditional Listing
12th Jul 20215:34 pmRNSDirector/PDMR Shareholding
9th Jul 20213:00 pmRNSResults of AGM
8th Jul 20215:46 pmRNSDirector/PDMR Shareholding
6th Jul 20217:00 amRNSTrading Statement
1st Jul 20211:15 pmRNSTotal Voting Rights
15th Jun 20213:15 pmRNSDirector/PDMR Shareholding
11th Jun 20213:00 pmRNSDirector/PDMR Shareholding
10th Jun 202112:00 pmRNSAdjustment of Conversion Price
7th Jun 20213:25 pmRNSAnnual Report and Notice of AGM 2021
4th Jun 20216:00 pmRNSDirector/PDMR Shareholding
1st Jun 20213:12 pmRNSTotal Voting Rights
1st Jun 20218:50 amRNSDirector Declaration
14th May 20213:05 pmRNSDirector/PDMR Shareholding
10th May 20215:15 pmRNSDirector/PDMR Shareholding
10th May 202112:00 pmRNSDirector/PDMR Shareholding
5th May 20212:30 pmRNSHolding(s) in Company
4th May 20212:15 pmRNSTotal Voting Rights
29th Apr 20213:30 pmRNSHolding(s) in Company
28th Apr 20217:00 amRNSFinal Results
16th Apr 20212:30 pmRNSDirector/PDMR Shareholding
13th Apr 20213:00 pmRNSHolding(s) in Company
13th Apr 20213:00 pmRNSHolding(s) in Company
13th Apr 20217:05 amRNSDirector Declaration
1st Apr 20213:10 pmRNSTotal Voting Rights
1st Apr 20211:45 pmRNSHolding(s) in Company
19th Mar 20213:30 pmRNSDirector/PDMR Shareholding
12th Mar 20219:00 amRNSDirectorate Changes
3rd Mar 20213:15 pmRNSSainsbury’s to forgo business rates relief
1st Mar 20212:30 pmRNSTotal Voting Rights
26th Feb 202112:30 pmRNSHolding(s) in Company
24th Feb 20214:55 pmRNSHolding(s) in Company
22nd Feb 20214:45 pmRNSHolding(s) in Company
19th Feb 20211:15 pmRNSDirector/PDMR Shareholding
5th Feb 20219:00 amRNSDirector Declaration
1st Feb 20214:10 pmRNSBlock listing Interim Review
1st Feb 20212:40 pmRNSTotal Voting Rights
29th Jan 20213:00 pmRNSHolding(s) in Company
25th Jan 202112:30 pmRNSDirector/PDMR Shareholding
19th Jan 202111:00 amRNSDirectorate Change
12th Jan 20211:00 pmRNSDirector/PDMR Shareholding
7th Jan 20217:00 amRNSQ3 Trading Statement
4th Jan 202112:20 pmRNSTotal Voting Rights
29th Dec 20202:00 pmRNSDirector/PDMR Shareholding
17th Dec 20207:00 amRNSDirectorate Change – Sainsbury’s Bank
15th Dec 202010:05 amRNSDirector/PDMR Shareholding
3rd Dec 20207:00 amRNSSainsbury’s to forgo business rates relief
1st Dec 20202:47 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.